Patrick Yu‐Wai‐Man

University of Cambridge

Papers

1

Total Citations

2

H-Index

1

About

Dr. Patrick Yu‐Wai‐Man is a leading figure in neuro-ophthalmology and mitochondrial medicine, whose research has fundamentally advanced our understanding of inherited optic neuropathies. His seminal work on Leber hereditary optic neuropathy (LHON) has been pivotal, with his studies on the natural history and treatment of this condition collectively garnering thousands of citations. Dr. Yu‐Wai‐Man’s major contributions include elucidating the genetic and clinical spectrum of LHON and dominant optic atrophy, and pioneering gene therapy approaches for these blinding disorders. His landmark clinical trials on idebenone for LHON have established a new standard of care, while his research on mitochondrial dysfunction has broader implications for neurodegenerative diseases. With over 200 publications and an h-index exceeding 60, his work has been recognized with prestigious awards from the Royal College of Ophthalmologists and the European Neuro-Ophthalmology Society. Dr. Yu‐Wai‐Man continues to shape the field through his leadership of the Cambridge Mitochondrial Medicine Group, where he trains the next generation of clinician-scientists in translating genetic discoveries into life-changing therapies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Digitalization of surgical features improves surgical accuracy via surgeon guidance and robotization
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: University of Cambridge

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago